Magnefar B6 tablets No. 60

Magnefar B6 tablets are indicated for the prevention and treatment of magnesium and pyridoxine hydrochloride (vitamin B6) deficiency conditions.

Composition

Active ingredients: magnesium hydroasparaginate tetrahydrate and pyridoxine hydrochloride;

1 tablet contains magnesium hydroaspartate tetrahydrate 500 mg (corresponding to 34 mg Mg2+) and pyridoxine hydrochloride 5 mg;

Excipients: microcrystalline cellulose, magnesium stearate, hypromellose.

Contraindication

Method of application

Magnefar® B6 is intended for internal use. Tablets should be taken after meals, washed down with water (at least 200-250 ml).

With magnesium and vitamin B6 deficiency:

For prevention: adults and children over 12 years of age are usually prescribed 1-2 tablets once a day.

Any increase in dose should be agreed with your doctor.

Application features

Pregnant women

The use of magnesium during pregnancy is possible only if necessary after consulting a doctor.

Children

The drug is used in children aged 6 years and older.

Drivers

No effect.

Overdose

Overdose of oral magnesium usually does not lead to toxic reactions in patients with normal renal function. However, magnesium intoxication may develop in patients with renal insufficiency.

Treatment: rehydration, forced diuresis. Patients with renal failure require hemodialysis or peritoneal dialysis.

Side effects

Allergic reactions, diarrhea, nausea, vomiting, abdominal pain, skin reactions, including itching and hives.

Interaction

Concomitant use with levodopa should be avoided, as the effect of levodopa has been shown to be reduced when its use is not accompanied by peripheral dopa decarboxylase inhibitors. The use of the vitamin in any quantities is not indicated if levodopa is not accompanied by dopa decarboxylase inhibitors.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 3 years.